deltatrials
Completed OBSERVATIONAL NCT03110432

Prospective German Very High Cardiovascular Risk Patients Dyslipidemia Treatment Indication Registry (PERI-DYS)

Sponsor: GWT-TUD GmbH

Conditions Dyslipoproteinemias Familial Combined Hyperlipidemia Familial Hypercholesterolemia - Homozygous Hypercholesterolemia, Familial
Interventions PCSK9 Inhibitor [EPC] Standard lipid lowering therapy
Updated 16 times since 2017 Last updated: May 6, 2025 Started: May 18, 2017 Primary completion: Apr 17, 2024 Completion: Apr 17, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03110432, this observational or N/A phase trial focuses on Dyslipoproteinemias and Familial Combined Hyperlipidemia and remains completed. Sponsored by GWT-TUD GmbH, it has been updated 16 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~May 2017 – ~Aug 2017 · 3 months · monthly snapshot~Aug 2017 – ~Apr 2018 · 8 months · monthly snapshot~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshot~Jun 2018 – ~Oct 2018 · 4 months · monthly snapshot~Oct 2018 – ~Mar 2019 · 5 months · monthly snapshot~Mar 2019 – ~Jan 2021 · 22 months · monthly snapshot~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshot~Mar 2021 – ~Sep 2021 · 6 months · monthly snapshot~Sep 2021 – ~Apr 2022 · 7 months · monthly snapshot~Apr 2022 – ~Nov 2022 · 7 months · monthly snapshot~Nov 2022 – ~Feb 2023 · 3 months · monthly snapshot~Feb 2023 – ~Mar 2024 · 13 months · monthly snapshot~Mar 2024 – ~Jul 2024 · 4 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Jun 2025 · 9 months · monthly snapshot~Jun 2025 – present · 13 months · monthly snapshot

Change History

16 versions recorded

  1. Jun 2025 — Present [monthly]

    Completed

    Status: Active Not Recruiting → Completed

  2. Sep 2024 — Jun 2025 [monthly]

    Active Not Recruiting

  3. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting

  4. Mar 2024 — Jul 2024 [monthly]

    Active Not Recruiting

  5. Feb 2023 — Mar 2024 [monthly]

    Active Not Recruiting

    Status: Recruiting → Active Not Recruiting

▶ Show 11 earlier versions

  1. Nov 2022 — Feb 2023 [monthly]

    Recruiting

  2. Apr 2022 — Nov 2022 [monthly]

    Recruiting

    Status: Active Not Recruiting → Recruiting

  3. Sep 2021 — Apr 2022 [monthly]

    Active Not Recruiting

    Status: Recruiting → Active Not Recruiting

  4. Mar 2021 — Sep 2021 [monthly]

    Recruiting

  5. Jan 2021 — Mar 2021 [monthly]

    Recruiting

  6. Mar 2019 — Jan 2021 [monthly]

    Recruiting

  7. Oct 2018 — Mar 2019 [monthly]

    Recruiting

  8. Jun 2018 — Oct 2018 [monthly]

    Recruiting

  9. Apr 2018 — Jun 2018 [monthly]

    Recruiting

    Phase: NA → None

  10. Aug 2017 — Apr 2018 [monthly]

    Recruiting NA

    Status: Not Yet Recruiting → Recruiting

  11. May 2017 — Aug 2017 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • GWT-TUD GmbH
Data source: GWT-TUD GmbH

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations